Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Dimensional Approach to Evaluate Reward Processing in Major Depressive Disorder Before and After Treatment With Desvenlafaxine

NCT02859103 is registered in ClinicalTrials.gov with Unity Health Toronto as lead sponsor.

NCT NCT02859103
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02859103 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Dimensional Approach to Evaluate Reward Processing in Major Depressive Disorder Before and After Treatment With Desvenlafaxine
Lead sponsor
Unity Health Toronto
Phase
Phase 4
Overall status
Completed
Start date
June 1, 2017
Completion date
November 4, 2019
Enrollment
56 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

anhedonia, depression